C, S., TA, H., J, S., H, M., RC, F., KA, M., . . . P, L. (2020). Assessing Nanopore Sequencing for Clinical Diagnostics: A Comparison of Next-Generation Sequencing (NGS) Methods for Mycobacterium tuberculosis. Journal of clinical microbiology, 59(1), . https://doi.org/10.1128/JCM.00583-20
Chicago Style (17th ed.) CitationC, Smith, Halse TA, Shea J, Modestil H, Fowler RC, Musser KA, Escuyer V, and Lapierre P. "Assessing Nanopore Sequencing for Clinical Diagnostics: A Comparison of Next-Generation Sequencing (NGS) Methods for Mycobacterium Tuberculosis." Journal of Clinical Microbiology 59, no. 1 (2020). https://doi.org/10.1128/JCM.00583-20.
MLA (9th ed.) CitationC, Smith, et al. "Assessing Nanopore Sequencing for Clinical Diagnostics: A Comparison of Next-Generation Sequencing (NGS) Methods for Mycobacterium Tuberculosis." Journal of Clinical Microbiology, vol. 59, no. 1, 2020, https://doi.org/10.1128/JCM.00583-20.